Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis.
about
Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-AnalysisHormone replacement therapy and physical function in healthy older men. Time to talk hormones?Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis.Growth hormone in anti-aging medicine: a critical review.Pharmacotherapy of osteoporosis in men.Clinical effects of growth hormone on bone: a review.More than osteoporosis: age-specific issues in bone health.Growth hormone, insulin-like growth factors, and the skeleton.Ghrelin and bone.Short Anabolic Peptides for Bone Growth.Skeletal effects of growth hormone and insulin-like growth factor-I therapy.Trabecular bone microstructure and local gene expression in iliac crest biopsies of men with idiopathic osteoporosis.Long-term skeletal effects of recombinant human growth hormone (rhGH) alone and rhGH combined with alendronate in GH-deficient adults: a seven-year follow-up study.Ibandronate increases sclerostin levels and bone strength in male patients with idiopathic osteoporosis.Growth Hormone Favorably Affects Bone Turnover and Bone Mineral Density in Patients With Short Bowel Syndrome Undergoing Intestinal Rehabilitation
P2860
Q28547459-8F7A3538-B17B-44E0-BDBC-78685A6AD2EAQ33569163-061A5EB2-D143-4C06-9501-2F31140AE237Q34043294-3AC702DA-609F-4B27-B233-0A95833D21C1Q35684580-EFEB0172-E921-4FC0-911B-B10BA67F3545Q36040673-CD1F6E3C-517C-4B76-9479-522406FFC684Q36084036-05199738-2995-4CA1-8E44-FD234426266CQ36877351-237A101D-D5ED-400E-8736-EB43FD78AA9AQ37147591-88CDBA9E-A22D-4454-AD25-3D7DE280E760Q38117311-D1C3D713-275C-4DC8-9980-F5ADB7071C66Q38864194-82839862-14E6-4690-9F2F-89A23A43515DQ39527508-37EF7F98-0B39-4C3A-A96E-E59BB329C48AQ43989185-1300CE2E-7D36-4CAB-956B-4A86F9EBE9FBQ44856197-8A7DC787-AE0B-47CD-BAFD-865942CF6D60Q53527845-F4C60E29-80C7-499E-8A91-B1DE404869B7Q57611559-2DED2EDF-346B-4BC5-A1A4-BDBB73A63301
P2860
Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Two years of treatment with re ...... with idiopathic osteoporosis.
@ast
Two years of treatment with re ...... with idiopathic osteoporosis.
@en
type
label
Two years of treatment with re ...... with idiopathic osteoporosis.
@ast
Two years of treatment with re ...... with idiopathic osteoporosis.
@en
prefLabel
Two years of treatment with re ...... with idiopathic osteoporosis.
@ast
Two years of treatment with re ...... with idiopathic osteoporosis.
@en
P2093
P356
P1476
Two years of treatment with re ...... with idiopathic osteoporosis.
@en
P2093
Anna G Nilsson
Hans Mallmin
Marianne Petrén-Mallmin
Peter Gillberg
Sverker Ljunghall
P304
P356
10.1210/JC.2002-020231
P407
P577
2002-11-01T00:00:00Z